Free Trial
OTCMKTS:TRGNF

Transgene (TRGNF) Stock Price, News & Analysis

Transgene logo
$0.75 0.00 (0.00%)
As of 11/13/2026

About Transgene Stock (OTCMKTS:TRGNF)

Advanced

Key Stats

Today's Range
$0.75
▼
$0.75
50-Day Range
$0.75
▼
$0.80
52-Week Range
$0.75
▼
$0.80
Volume
N/A
Average Volume
775 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Transgene is a French biotechnology company that develops immunotherapies, with a primary focus on treatments for cancer. Its research centers on therapeutic vaccines and oncolytic viruses—engineered viruses designed to target tumors and stimulate an immune response.

The company’s pipeline includes candidates using viral-vector platforms, including personalized approaches intended to tailor treatment to the characteristics of an individual patient’s tumor. Transgene advances its programs through research and clinical development, often working with academic and industry partners.

Founded in 1979 and headquartered in Strasbourg, France, Transgene conducts clinical development internationally. Its work reflects a broader effort to develop immune-based treatments for cancer, including therapies that may be used alongside other cancer treatments.

AI Generated. May Contain Errors.

Receive TRGNF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Transgene and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TRGNF Stock News Headlines

Transgene SA (OTCMKTS:TRGNF) Stock Short Interest Report for October
Why I'm selling my Snapback Indicator for just $7
For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indicator for a single $7 payment. Others previously paid $500. The indicator flashes a Crash Alert as a cue to exit or go short, and a Bull Run Alert as a cue to buy or go long. No strings attached, and Wood says there is an unusual reason behind the steep discount.tc pixel
Transgene SA (TRGNF) Q4 2025 Earnings Call Transcript
Transgene SA (TRGNF) Q2 2025 Earnings Call Transcript
See More Headlines

TRGNF Stock Analysis - Frequently Asked Questions

Transgene's stock was trading at $1.00 on January 1st, 2026. Since then, TRGNF shares have decreased by 25.5% and is now trading at $0.7452.

Shares of TRGNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
OTCMKTS:TRGNF
CIK
N/A
Fax
N/A
Employees
146
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

This page (OTCMKTS:TRGNF) was last updated on 11/13/2026 by MarketBeat.com Staff.
From Our Partners